ALK
Drug: Alectinib
Cancer code: DLBC
Cancer type: B_cell_lymphoma
Drug treatment table
| Cell line ID |
Cell line name |
Mutation in substructure |
IC50(uM) |
| SIDM00859 | Farage | A_loop (1289) | 37.2207 |
| SIDM00886 | DB | None | 48.035 |
| SIDM00661 | HT | None | 43.5188 |
| SIDM01008 | KARPAS-422 | None | 50.4081 |
| SIDM00637 | MC116 | None | 15.739 |
| SIDM01205 | TUR | None | 37.7232 |
| SIDM01089 | RL | None | 55.1124 |
| SIDM00895 | BC-3 | None | 17.6754 |
| SIDM00896 | BC-1 | None | 27.5005 |
| SIDM00384 | SCC-3 | None | 0.0654 |
| SIDM00502 | A4-Fuk | None | 41.7982 |
| SIDM00495 | A3-KAW | None | 9.0696 |
| SIDM00283 | CTB-1 | None | 28.993 |
| SIDM01058 | GRANTA-519 | None | 57.3431 |
| SIDM00689 | JM1 | None | 12.5247 |
| SIDM00688 | JSC-1 | None | 41.8166 |
| SIDM00443 | NU-DUL-1 | None | 12.326 |
| SIDM00460 | OCI-LY-19 | None | 28.3181 |
| SIDM00448 | RC-K8 | None | 52.4076 |
| SIDM00374 | SLVL | None | 53.5803 |
| SIDM00389 | SU-DHL-10 | None | 15.584 |
| SIDM00404 | SU-DHL-16 | None | 15.5928 |
| SIDM00405 | SU-DHL-4 | None | 16.3902 |
| SIDM00406 | SU-DHL-5 | None | 10.5082 |
| SIDM00407 | SU-DHL-6 | None | 12.4058 |
| SIDM00423 | SU-DHL-8 | None | 15.0244 |
| SIDM00323 | TK | None | 27.6015 |
| SIDM00416 | VAL | None | 30.3615 |
| SIDM00413 | WSU-DLCL2 | None | 36.2818 |
